open
SAI PARENTSai Parenteral’s IPO
Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.
Advertisement (Slot: header)
Price Band
🟡
Lot Size
0 Shares
Issue Size
Approx ₹409 Crores
Current GMP
₹0 (Apr 2)
IPO Timeline
Open DateApril 2, 2026
Close DateApril 2, 2026
Basis of AllotmentTBA
Listing DateMarch 27, 2026
Subscription Status
Overall subscription
Financial Information
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹97.03 | ₹89.78 | ₹4.38 | ₹133.96 |
| 2024 | ₹155.18 | ₹142.63 | ₹8.42 | ₹268.10 |
| 2025 | ₹163.74 | ₹143.84 | ₹14.43 | ₹272.39 |
| Sep 2025 | ₹89.43 | ₹78.27 | ₹7.76 | ₹376.24 |
Promoters
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 3,69,08,823 | 61.23% |
| Promoter Holding Post Issue | 4,41,79,231 | -% |
Objects of the Issue
- Arihant Capital Markets Ltd.